Mode of transmisison: droplet - one of most infectious!; R0 = 12-18 in developed countries

Incubation: 10d: maybe 7-18d from exposure to onset of fever

Period of infectivity: 5d before to 5d after rash onset - day of rash onset = d1

Vaccines: live attenuated vaccine

  • MMR

  • egg allergy NOT contraindicaiton

Schedule: 15mo and 4yr

efficacy: very effective

Herd: need 95% immunisation

  • RNA virus

  • humans = only natural host

clinical

  • prodromal phase of 2-4days with:

    • fever

    • 3 C’s

      • cough

      • conjunctivitis

      • coryza

    • Koplik’s spots

  • maculopapular rash

    • first behind ears on 3-7d

    • speads over from head and face -> trunk

  • convalescnet stage

    • temporary brownish stain on skin
  • complications

    • AOM

    • pneumonia

    • croup

    • diarrhoea

    • encephalitis:

      • 1:1000

        • 15% die

        • 25-35% left with permanent neurological damage

    • sub-acute sclerosing panencephalitis

      • fatal

      • typcially 7-10yrs after wild type measles virus infection

  • vitamin a associated with dec mortality/morbidity

    • od for 2d at:

      • 200 000IU ≥12mo

      • 100 000 IU 6-11mo

      • 50 000 IU \<6mo

Expected response

  • fever >39.4 in 5-15%

  • lasts 1-2d

  • rash 5%: 6-12d after immunisation

  • most causes unrelated to immunisation

  • mumps:; parotid and/or submaxillary swelling

  • rubella; mild rash, fever, lymphadenopathy 2-4wl

  • febrile seizures 1:3000 6-12d after immunisation

  • increased fisk of ITP

During outbreak

  • MMR can be given to unvaccinated people, who are not immunocompromised, within 72h of exposure - this may prevent infection

    • lahtough immune response may not be very effective; can be given 6-12mo if being reported in young children

    • still require 2 doses

  • Human normal immunoglobulin

    • CI to MMR

    • immunocompromised children and adults

    • pregnant women

    • children \<15mo and >72hrs post exposure

    • >82hrs exposre no history or no MMR

    • given ASAP after eposure

      • can be given up to 6d

      • not within 3wk of live virurs

      • live virus not 11mo after

  • IVIG - Intragam P

    • IV compared to IM

    • immunocompromised